Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial of PEHRG214 in HIV-Infected Patients

This study has been terminated.
(Difficulty recruiting eligible patients in timely fashion)
Information provided by:
Virionyx Corporation Limited Identifier:
First received: October 1, 2006
Last updated: August 24, 2010
Last verified: August 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2008
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)